leadf
logo-loader
viewFastForward Innovations Limited

FastForward Innovations’ Portage Biotech makes additional investment in cancer immunotherapy firm Stimunity

Portage has invested €900,000 into Stimunity, which it said will allow it to start manufacturing its biologic cGAMP-VLP (STI-001) lead compound

FastForward Innovations Limited - FastForward Innovations’ Portage Biotech makes additional investment in cancer immunotherapy firm Stimunity

FastForward Innovations Ltd (LON:FFWD) revealed that its portfolio firm, Portage Biotech Inc (CSE:PBT.U) (OTCMKTS:PTGEF), has made an additional investment in cancer immunotherapy firm Stimunity.

The AIM-listed investment firm said Portage has invested €900,000 into Stimunity after the firm reached a “major milestone” in its preclinical development plan, adding that the additional funds will allow it to start manufacturing its biologic cGAMP-VLP (STI-001) lead compound.

READ: FastForward Innovations portfolio company says cancer therapy developer meets milestone

Stimunity’s treatments focus on stimulator of interferon genes (STING) agonists, which can help stimulate immune system responses against cancer tumours.

"We knew since the beginning of the company that STING-activating cGAMP Virus-Like Particle (cGAMP-VLP) technology has a unique property enabling its payload to preferentially target immune cells, which is different from other chemical STING approaches”, Nicolas Manel, co-founder and scientific advisor of Portage said in a statement.

“This has an impact on the stimulation of the immune system and the quality of the anti-tumoral response. We have determined that this targeting mechanism is able to deliver the cGAMP via systemic route of administration and that it leads to induction of systemic anti-tumor T-cell response", he added.

Shares in FastForward, which owns a 1.18% interest in Portage, rose 2.4% to 6.5p in mid-morning trading on Tuesday.

Quick facts: FastForward Innovations Limited

Price: 8.25 GBX

LSE:FFWD
Market: LSE
Market Cap: £15.27 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of FastForward Innovations Limited named herein, including the promotion by the Company of FastForward Innovations Limited in any Content on the...

FOR OUR FULL DISCLAIMER CLICK HERE

FastForward to capitalise on 'oven ready opportunities' in medical cannabis...

FastForward Innovations' (LON:FFWD) Ed Mcdermott explains to Proactive why the investment group has decided to raise around £2m through the placing of 23.5m new shares. Mcdermott says there are now 'oven ready opportunities' in medical cannabis space after new guidance from the Financial...

on 13/10/20

2 min read